Poniard Pharmaceuticals, Inc. (PARD)

Poniard Pharmaceuticals Statistics

Total Valuation

Poniard Pharmaceuticals has a market cap or net worth of 1.

Market Cap	1
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Poniard Pharmaceuticals has 1.50 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.65%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 0.53.

Current Ratio	0.76
Quick Ratio	0.67
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-26.71

Financial Efficiency

Return on equity (ROE) is -210.37% and return on invested capital (ROIC) is -57.06%.

Return on Equity (ROE)	-210.37%
Return on Assets (ROA)	-46.03%
Return on Capital (ROIC)	-57.06%
Revenue Per Employee	n/a
Profits Per Employee	-2.03M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-36.03
52-Week Price Change	n/a
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	0.00
Average Volume (20 Days)	6

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.32M
Pretax Income	-16.04M
Net Income	-16.23M
EBITDA	-13.04M
EBIT	-14.32M
Earnings Per Share (EPS)	-3.79

Balance Sheet

The company has 1.98 million in cash and 1.64 million in debt, giving a net cash position of 344,000 or 0.23 per share.

Cash & Cash Equivalents	1.98M
Total Debt	1.64M
Net Cash	344,000
Net Cash Per Share	0.23
Equity (Book Value)	3.12M
Book Value Per Share	2.08
Working Capital	-727,000

Cash Flow

In the last 12 months, operating cash flow was -10.46 million and capital expenditures -9,000, giving a free cash flow of -10.47 million.

Operating Cash Flow	-10.46M
Capital Expenditures	-9,000
Free Cash Flow	-10.47M
FCF Per Share	-6.98

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Poniard Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-289.32%
Shareholder Yield	-289.32%
Earnings Yield	-379,095,800.00%
FCF Yield	-698,124,748.61%

Stock Splits

The last stock split was on November 23, 2011. It was a reverse split with a ratio of 0.025.

Last Split Date	Nov 23, 2011
Split Type	Reverse
Split Ratio	0.025

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a